Vestor Capital’s Veracyte VCYT Stock Holding History

Vestor Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$181K	Buy	+765	New	+$32.1K	0.01%	161

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vestor Capital's VCYT Position: Q2 2026 in Review

Vestor Capital opened a new position in Veracyte (VCYT) in Q2 2026: 765 shares worth $181K. The stake represents 0.01% of the portfolio and ranks #161 among its holdings.

369 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Vestor Capital held 765 shares of Veracyte worth $181K as of Q2 2026.
Veracyte was a new Vestor Capital position in Q2 2026.
Veracyte made up 0.01% of Vestor Capital's portfolio in Q2 2026, its #161 holding.
369 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.